Navigation Links
Endpoints - Clinical Trials in Respiratory Diseases - Pulmonary Function Tests, Biomarkers and Quality of Life Questionnaires All Play Prominent Roles
Date:8/27/2012

.4.4 Colistimethate sodium (Colistin, Colomycin Injection, Promixin, Coly-Mycin M) 1326.5 Cystic Fibrosis – Promising Drugs Under Clinical Development 1336.5.1 Denufosol Tetrasodium Inhalation Solution (INS37217) 1336.5.2 VX-770 1346.5.3 Bronchitol 1346.5.4 Ataluren (PTC-124) 1356.6 Phase III – Clinical Trial Analysis 1366.6.1 Completed Trial Analysis 1366.6.2 Active Trial Analysis 1386.6.3 Terminated Trial Analysis 1416.7 Phase II – Clinical Trial Analysis 1436.7.1 Completed Trial Analysis 1436.7.2 Active Trial Analysis 1466.7.3 Terminated Trial Analysis 1497 Endpoints - Clinical Trials in Pulmonary Arterial Hypertension - Marketed and Pipeline Products Assessment 1567.1 Introduction 1567.1.1 Classification of Pulmonary Hypertension 1567.2 Primary Endpoints Used in Pulmonary Hypertension Trials 1617.2.1 Cardiopulmonary Hemodynamic Test 1617.2.2 Six Minutes Walking Distance 1617.2.3 Biomarkers 1617.3 Secondary Endpoints Used in Pulmonary Hypertension Trials 1617.3.1 Time to Clinical Worsening 1617.3.2 SF-36 Health Survey 1617.4 Pulmonary Arterial Hypertension – Major Marketed Drugs 1617.4.1 Tracleer 1617.4.2 Remodulin 1627.4.3 Revatio 1637.4.4 Ventavis 1647.4.5 Letairis 1657.4.6 Adcirca 1667.5 Pulmonary Arterial Hypertension – Promising Drugs under Clinical Development 1677.5.1 ACT-064992 1677.5.2 Oral Treprostinil 1687.5.3 ACT-293987 1687.5.4 Riociguat (BAY63-2521) 1697.6 Phase III Clinical Trial Analysis 1707.6.1 Completed Trial Analysis 1707.6.2 Active Trial Analysis 1727.6.3 Terminated Trial Analysis 1757.7 Phase II Clinical Trial Analysis 1777.7.1 Completed Trial Analysis 1777.7.2 Active Trial Analysis 1807.7.3 Terminated Trial Analysis 1838 Endpoints - Clinical Trials in Respiratory Diseases - Company Profiling 1878.1 GlaxoSmithKline Plc 1878.1.1 Overview 1878.1.2 Respiratory Disease Portfolio 1878.2 AstraZeneca 1888.2.1 Overview 1888.2.2 Respiratory Disease Portfolio 1888.3 F.Hoffmann La Roche 1888.3.1 Overview 1888.3.2 Respirato
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
2. As Tuberculosis Grows More Difficult to Control, Vaccine Candidate to Prevent Disease Enters Clinical Testing
3. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
4. VolitionRX to Begin Prospective Clinical Trial in Colon Cancer
5. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
6. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
7. AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
8. Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs
9. Meritage Pharma Initiates Clinical Trial of Oral Budesonide Suspension for Adolescent and Adult Patients with Eosinophilic Esophagitis
10. MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models
11. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015  Chiasma, Inc., ... lead product for the orphan condition acromegaly, today announced ... round. Participants in the financing included new investors Rock ... chip public investment fund, as well as existing investors ... and ARCH Venture Partners. Chiasma intends ...
(Date:2/26/2015)... CHICAGO, Ill. , Feb. 26, 2015 /PRNewswire/ ... that 15 abstracts of studies in its neuroscience ... presentation during the 67 th American Academy ... D.C. , from April 18-25. The accepted ... product, DUOPA, in addition to investigational treatments in ...
(Date:2/26/2015)... -- Legislation passed today by the House Ways and ... inappropriate prescriptions in Medicare Part D from crossing the ... Act (PIMA) of 2014 , introduced by Ways and ... and Ranking Member Jim McDermott (D-WA), recognizes the need ... the right policies, said the Pharmaceutical Care Management Association ...
Breaking Medicine Technology:Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2
... Inc. (Nasdaq: CRDC ) today announced that it will ... 2011, on Thursday, October 27, 2011, after the markets close. Cardica,s ... to discuss the financial results and provide an update on the ... To access the live conference call on October 27, 2011 ...
... Oct. 20, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited ... and marketer of medical devices worldwide, today announced that ... quarter ended September 30, 2011 after the U.S. market ... an earnings conference call at 8:00 AM on November ...
Cached Medicine Technology:Cardica to Announce Fiscal 2012 First Quarter Financial Results on Thursday, October 27, 2011 2Mindray to Report Third Quarter 2011 Financial Results on November 7, 2011 2
(Date:2/28/2015)... (PRWEB) February 28, 2015 March—also ... good time to remind ourselves and others that ... say Atlantic NeuroSurgical Specialists (ANS). , Concussions are ... account for 75% of TBIs. There are 1.6-3.8 ... may sound benign, but it is a brain ...
(Date:2/28/2015)... Bethesda, MD (PRWEB) February 28, 2015 ... annual conference in person, the Mesothelioma Applied Research ... taking place on Tuesday, March 3, starting at 9:30 ... and requires no registration. The broadcast can be accessed ... visiting http://www.curemeso.org/symposium . , The Symposium is a ...
(Date:2/28/2015)... Orlando, FL (PRWEB) February 28, 2015 ... community organization has sponsored visitor health insurance programs for ... 25 years. Most Indian elderly parents traveling to the ... conditions such as diabetes and blood pressure. These diseases ... do not even list them as medical conditions. There ...
(Date:2/28/2015)... 2015 The noted Friedman Dental Group ... have officially relaunched their website. The new version of ... contains a new section about their team members. Potential ... full biographies of each Friedman Dental Group team member ... was designed to provide our patients with the opportunity ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Plugin creators ... TransFold Volume 2. A fully customizable transition ... “TransFold Volume 2 gives users total control over 30 ... Austin, CEO of Pixel Film Studios. “TransFold Volume 2 ... editor.” , TransFold Volume 2 from Pixel Film Studios ...
Breaking Medicine News(10 mins):Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2
... following Congress, failure,to override SCHIP veto, WASHINGTON, Oct. ... Fattah:, "It,s a sad day when America,s children ... for and look after their most basic needs. It,s,a ... defend its most,vulnerable citizens., "The failure of the ...
... Must Happen Before Congressional Thanksgiving Break on State,Children,s ... "Congress cannot go home,to its Thanksgiving break ... of mind for America,s laboring families by passing ... Delgado, President and CEO of the,National Alliance for ...
... the Northern California Cancer Center, the University of Southern ... found that increased exposure to sunlight which increases ... decrease the risk of advanced breast cancer. , In ... Journal of Epidemiology, the researchers found that women with ...
... 2007 Research will be reported at TCT 2007, ... (CRF), that demonstrates that early intervention saves lives in ... pain. , Responding to media reports of recent studies ... to men, Dr. Alexandra J. Lansky, MD, Director of ...
... half of sufferers are kept awake by a variety of ... Along with typical symptoms such as acid reflux, the less ... coughing, choking, wheezing, choking, snoring, sore throat, and chest pain ... new U.S. survey. , The poll of 701 GERD patients ...
... Oct. 18 Following is a statement from ... the House,s failure to,override President Bush,s veto of ... of the Congressional Democrats and,some courageous Republicans to ... health care to children whose parents cannot,afford it. ...
Cached Medicine News:Health News:Exposure to sunlight may decrease risk of advanced breast cancer by half 2Health News:Exposure to sunlight may decrease risk of advanced breast cancer by half 3Health News:Are women at greater risk from angioplasty? 2
... HF35-50 High Frequency Ultrasound system is the ... frequency system available. The HF35-50 allows users ... the anterior segment with 35MHz or 50MHz ... with a 20 MHz sealed B-probe. , ...
... accurate digital A-scan system. The combination of ... fast precise algorithm enables scan capture immediately ... visual axis. The A5500 A-scan provides: live ... thermal printer, 5 different examination modes, measurement ...
... The Microscan 100A+ is extremely portable, ... kg). The digital A-scan system provides a ... a high frequency, low noise probe and ... upon application of the probe along the ...
... workstation. Accurate, efficient and easy to use. ... a variety of regressive, theoretical, and adaptive ... of the patient. Convenient design features improve ... for hands-free operation, audible tone to minimize ...
Medicine Products: